)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
AVITA Medical
AVITA Medical (RCEL) investor relations material
AVITA Medical Morgan Stanley 24th Annual Global Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Morgan Stanley 24th Annual Global Healthcare Conference summary16 Sep, 2026
Leadership and operational focus
New CEO prioritized solving fixable issues and maximizing company potential, emphasizing focus and execution over the past 9-10 months.
Streamlined operations by eliminating distractions, implementing effective compensation plans, and ensuring organizational alignment.
Consistent internal and external messaging and placing the right people in key roles have driven recent growth.
Growth strategy and commercial execution
Achieved strong sequential growth over the last three quarters, leading to raised 2026 guidance.
Focused on deepening penetration within existing 200 accounts, with significant room for growth across three product lines.
Sales team efficiency and effectiveness are enhanced by offering a portfolio approach, building trust and consultative relationships with customers.
Product adoption and market opportunity
Barriers to adoption include the need for clinical, workflow, and economic arguments to change physician habits.
RECELL demonstrates clinical benefits such as faster healing, better pigmentation, and a 36% reduction in length of stay.
Expansion into trauma and surgical repair is underway, but burn remains the core focus due to high penetration potential.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from AVITA Medical
- PermeaDerm delivers a 70% cost reduction, workflow benefits, and clinical outcomes on par with allograft.RCEL
KOL event - 2026 guidance raised to $86–$89M, with Q4 breakeven targeted and strong Q2 revenue growth.RCELInvestor update
- Revenue growth, margin stability, and product adoption drive confidence in sustained expansion.RCELCanaccord Genuity's 46th Annual Growth Conference
- Q2 2026 revenue up 18% year-over-year; guidance raised, but going concern risk remains.RCELQ2 2026
- Sequential revenue growth, strong margins, and reaffirmed guidance signal renewed momentum.RCELStatus update
- Revenue up 4% to $19.3M, net loss narrows, but going concern risk remains.RCELQ1 2026
- Shareholders will vote on director elections, compensation, equity grants, and key capital changes.RCELProxy filing
- 2026 guidance targets $80–$85M revenue, with growth, reimbursement clarity, and new financing.RCELStatus update
- Q2 2024 revenue up as much as 44% to $19.5M; 2024 guidance set at $68–$70M.RCELQ2 2024
Next AVITA Medical earnings date
Q3 20265 Nov, 2026
AVITA Medical
Next AVITA Medical earnings date
Q3 20265 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
AVITA Medical Inc is a regenerative medicine company that develops and markets therapeutic solutions for skin restoration. Its primary product is a spray-on skin system used for treating burns, wounds, and dermatological conditions. The company operates in North America and internationally through partnerships and direct sales. AVITA Medical Inc is headquartered in Valencia, California, and its shares are listed on the NASDAQ.